April 04,2007
Grassley Seeks Marketing and Safety Documents from Major Drug Maker
WASHINGTON — Sen. Chuck Grassley is asking the drug maker, Eli Lilly and Company, for information related to the risks and marketing of the anti-psychotic drug Zyprexa. Grassley made this request in response to allegations that the company downplayed safety risks and engaged in other improper marketing practices that may be jeopardizing patients’ health.
The text of Grassley’s letter can be found in the printer-friendly version of this news release.
###
Next Article Previous Article
Recent News
- Wyden Calls for Full IRS Investigation of Tax Shelter Involving Puerto Rico Residency, Unveils New Findings in Ongoing Investigation
- Wyden Continues Inquiry into Treasury Mishandling Iran War Fallout as Bessent Dodges Key Questions
- Wyden Demands Transparency on Robert Kennedy’s Recreational Drug Use Following Reporter’s Tell-All Book
- Wyden Finance Committee Hearing Statement Slamming Trump and RFK Jr.'s Disastrous Health Care Agenda
- While Trump Delays, Wyden Calls for Passage of Speedy Tariff Refunds Act